Kenneth D Swanson Selected Research

Kenneth D Swanson Research Topics

Disease

15	Neoplasms (Cancer) 04/2022 - 03/2008
10	Glioblastoma (Glioblastoma Multiforme) 01/2019 - 06/2014
4	Melanoma (Melanoma, Malignant) 12/2022 - 12/2010
3	Prostatic Neoplasms (Prostate Cancer) 01/2021 - 01/2012
3	Glioma (Gliomas) 01/2018 - 08/2015
3	Noonan Syndrome (Female Pseudo-Turner Syndrome) 05/2010 - 03/2006
2	Infections 12/2022 - 01/2020
2	Neoplasm Metastasis (Metastasis) 01/2021 - 04/2014
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 11/2017 - 03/2008
1	COVID-19 12/2022
1	Inflammation (Inflammations) 09/2022
1	Fibrosis (Cirrhosis) 09/2022
1	Liver Cirrhosis (Hepatic Cirrhosis) 09/2022
1	Ovarian Neoplasms (Ovarian Cancer) 04/2022
1	Endometriosis 04/2022
1	Hemolysis 01/2021
1	Hepatitis 01/2020
1	Neonatal Jaundice 01/2020
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 11/2018
1	Disease Progression 04/2014
1	LEOPARD Syndrome (Syndrome, LEOPARD) 05/2010
1	Neuroblastoma 03/2008
1	Carcinoma (Carcinomatosis) 03/2008
1	Breast Neoplasms (Breast Cancer) 01/2002

Drug/Important Bio-Agent (IBA)

3	Heme (Haem)IBA 04/2022 - 01/2020
3	Dexamethasone (Maxidex)FDA LinkGeneric 01/2019 - 03/2015
2	Heme Oxygenase-1IBA 09/2022 - 04/2022
2	EnzymesIBA 04/2022 - 09/2010
2	CytokinesIBA 04/2022 - 04/2014
2	Phenformin (Fenformin)IBA 01/2021 - 01/2017
2	Temozolomide (Temodar)FDA LinkGeneric 12/2018 - 03/2015
2	Non-Receptor Type 11 Protein Tyrosine PhosphataseIBA 05/2010 - 01/2007
1	Immune Checkpoint InhibitorsIBA 12/2022
1	AntigensIBA 12/2022
1	AgarIBA 04/2022
1	Interleukin-10 (Interleukin 10)IBA 04/2022
1	CarbonIBA 01/2021
1	BiguanidesIBA 01/2021
1	Antineoplastic Agents (Antineoplastics)IBA 01/2021
1	Bile Pigments (Bilin)IBA 01/2020
1	NADPH Oxidases (NAD(P)H oxidase)IBA 01/2020
1	Biliverdine (Biliverdin)IBA 01/2020
1	BilirubinIBA 01/2020
1	Everolimus FDA Link 10/2018
1	Transcription Factors (Transcription Factor)IBA 11/2017
1	plerixafor FDA Link 01/2017
1	cabozantinibIBA 01/2017
1	Tyrosine Kinase InhibitorsIBA 01/2017
1	Chemotactic FactorsIBA 01/2017
1	Phosphotransferases (Kinase)IBA 01/2017
1	HMGB1 Protein (HMG1)IBA 01/2017
1	Bevacizumab (Avastin)FDA Link 03/2015
1	SeptinsIBA 01/2015
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2015
1	PoisonsIBA 01/2015
1	Interleukin-5 (Interleukin 5)IBA 04/2014
1	ChemokinesIBA 04/2014
1	Interleukin-4 (Interleukin 4)IBA 04/2014
1	Biomarkers (Surrogate Marker)IBA 06/2012
1	AndrogensIBA 01/2012
1	Androgen Receptors (Androgen Receptor)IBA 01/2012
1	Mechanistic Target of Rapamycin Complex 1IBA 01/2012
1	Mechanistic Target of Rapamycin Complex 2IBA 01/2012
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 01/2012
1	Glycoproteins (Glycoprotein)IBA 12/2010
1	Histidine (L-Histidine)FDA Link 09/2010
1	Pyruvate KinaseIBA 09/2010
1	Glucose (Dextrose)FDA LinkGeneric 09/2010
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 05/2010
1	Messenger RNA (mRNA)IBA 05/2010
1	DNA (Deoxyribonucleic Acid)IBA 03/2008
1	Tyrosine (L-Tyrosine)FDA Link 01/2007
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 01/2007
1	ras Guanine Nucleotide Exchange FactorsIBA 01/2007
1	Protein Tyrosine PhosphatasesIBA 03/2006
1	Tamoxifen FDA LinkGeneric 01/2002
1	Hormones (Hormone)IBA 01/2002
1	SteroidsIBA 01/2002

Therapy/Procedure

12	Therapeutics 01/2021 - 01/2012
6	Drug Therapy (Chemotherapy) 01/2019 - 06/2014
1	Ligation 09/2022
1	Immunotherapy 01/2017